We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$72.8B
AUM Growth
+$380M
Cap. Flow
+$6.81B
Cap. Flow %
9.36%
Top 10 Hldgs %
21.9%
Holding
3,928
New
233
Increased
1,953
Reduced
1,289
Closed
138

Top Sells

Rank Stock Value
1
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$246M
2
VST icon
Vistra
VST
+$94.2M
3
PM icon
Philip Morris
PM
+$70.3M
4
APP icon
Applovin
APP
+$61.7M
5
LLY icon
Eli Lilly
LLY
+$57.3M

Sector Composition

Rank Sector Weight
1 Technology 24.46%
2 Financials 14%
3 Healthcare 10.99%
4 Consumer Discretionary 10.5%
5 Communication Services 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTI icon
3601
Drilling Tools International
DTI
$87.1M
$353 ﹤0.01%
+149
New +$461
EVLV icon
3602
Evolv Technologies
EVLV
$1.08B
$349 ﹤0.01%
112
NPWR icon
3603
NET Power
NPWR
$141M
$345 ﹤0.01%
+131
New +$925
ARDT
3604
Ardent Health
ARDT
$1.58B
$344 ﹤0.01%
+25
New +$365
GCTS
3605
GCT Semiconductor Holding
GCTS
$188M
$341 ﹤0.01%
208
-3,275
-94% -$6.99K
FBT icon
3606
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$340 ﹤0.01%
2
-4
-67% -$695
PAA icon
3607
Plains All American Pipeline
PAA
$16.4B
$340 ﹤0.01%
17
TELO icon
3608
Telomir Pharmaceuticals
TELO
$79.1M
$336 ﹤0.01%
+104
New +$455
EDU icon
3609
New Oriental
EDU
$8.89B
$335 ﹤0.01%
7
PDN icon
3610
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$365M
$335 ﹤0.01%
+10
New +$332
NVAX icon
3611
Novavax
NVAX
$1.29B
$333 ﹤0.01%
52
AVXL icon
3612
Anavex Life Sciences
AVXL
$319M
$326 ﹤0.01%
+38
New +$359
MLPX icon
3613
Global X MLP & Energy Infrastructure ETF
MLPX
$3.55B
$319 ﹤0.01%
+5
New +$315
ABOS icon
3614
Acumen Pharmaceuticals
ABOS
$176M
$306 ﹤0.01%
278
-959
-78% -$1.37K
DH icon
3615
Definitive Healthcare
DH
$71.4M
$306 ﹤0.01%
+106
New +$430
MODV
3616
DELISTED
ModivCare
MODV
$299 ﹤0.01%
227
-894
-80% -$4.33K
FRST icon
3617
Primis Financial Corp
FRST
$403M
$293 ﹤0.01%
30
-91
-75% -$971
SGHT icon
3618
Sight Sciences
SGHT
$434M
$288 ﹤0.01%
120
ACCO icon
3619
Acco Brands
ACCO
$402M
$285 ﹤0.01%
68
-464
-87% -$2.28K
PCT icon
3620
PureCycle Technologies
PCT
$1.44B
$284 ﹤0.01%
+41
New +$369
TDUP icon
3621
ThredUp
TDUP
$407M
$280 ﹤0.01%
+116
New +$267
BNTX icon
3622
BioNTech
BNTX
$23.1B
$273 ﹤0.01%
+3
New +$336
AMPS
3623
DELISTED
Altus Power
AMPS
$272 ﹤0.01%
55
OPRA
3624
Opera Ltd
OPRA
$1.79B
$271 ﹤0.01%
17
+3
+21% +$56
LXU icon
3625
LSB Industries
LXU
$732M
$264 ﹤0.01%
40
-21
-34% -$164

Similar funds

Russell Investments Group's Q1 2025 Portfolio in Review

As of Q1 2025, Russell Investments Group held 3,928 positions worth $72.8B, up 0.52% from $72.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Russell Investments Group deployed $6.81B of net new capital in Q1 2025, opening 233 new positions and adding to 1,953 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 3,389,000 shares worth $4.07M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Bank of America Series L, an estimated $246M trimmed.

  • Russell Investments Group's largest Q1 2025 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 3,389,000 shares worth $4.07M.
  • Russell Investments Group added most to Apple in Q1 2025, an estimated $167M increase.
  • Russell Investments Group's biggest Q1 2025 reduction was Bank of America Series L, cutting an estimated $246M.
  • Russell Investments Group fully exited Arcadium Lithium plc in Q1 2025, selling an estimated $9.31M.
  • Russell Investments Group's ten largest holdings make up 22% of its $72.8B portfolio in Q1 2025.
  • Russell Investments Group opened 233 new positions and closed 138 in Q1 2025.
  • Russell Investments Group's portfolio value rose 0.52% quarter-over-quarter to $72.8B.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.